| Literature DB >> 31788487 |
Maria-Zoi Oikonomakou1, Olga E Makri2, Eleni Panoutsou1, Konstantinos Kagkelaris2, Panagiotis Plotas2, Dionysia Garatziotou3, Constantinos D Georgakopoulos2, Maria I Eliopoulou1.
Abstract
Acute bacterial conjunctivitis is a common, highly contagious infection in children and is usually treated empirically with broad spectrum topical antibiotics. In the current study we investigated bacteriology and antibiotic susceptibility patterns in childhood acute bacterial conjunctivitis in Western Greece. We conducted a retrospective analysis of presumed acute bacterial conjunctivitis cases in ''Karamandaneio'' Pediatric General Hospital of Patras, Western Greece, between February 1, 2013 and January 31, 2018. Specimens from the lower conjunctiva fornix were isolated from 191 cases and outcomes were analyzed to identify the pathogenic bacteria of acute bacterial conjunctivitis and their corresponding antibiotic susceptibility patterns. Patients were divided into 3 groups; Group A included neonates under 28 days of life, Group B children from 1 month to 2 years and Group C from 2 years to 14 years. Results revealed that Staphylococcus spp., Haemophilus spp. and Streptococcus spp. were the most prevalent pathogens. No significant differences in isolated pathogens were found between the age groups. Antibiotic resistance rates were higher against ampicillin, ceftriaxone, ceftazidime and sulfamethoxazole. Resistance rates to Ciprofloxacin were low while none of the evaluated isolates were resistant to vancomycin. We concluded that predominant pathogens of childhood acute bacterial conjunctivitis in Western Greece were Staphylococcus spp., Haemophilus spp. and Streptococcus spp. Continuous surveillance, focused in distinct geographic areas, is encouraged to prepare more precise protocols of empirical treatment.Entities:
Keywords: Anti-Bacterial Agents; Child; Haemophilus; Infant; Newborn; Staphylococcus; Streptococcus
Year: 2019 PMID: 31788487 PMCID: PMC6778672
Source DB: PubMed Journal: Med Hypothesis Discov Innov Ophthalmol ISSN: 2322-3219
Culture Results From Samples of Childhood Acute Bacterial Conjunctivitis
| Result | Number of specimens | Percentage |
|---|---|---|
| Sterile culture | 70 | 36.6 |
| Flora | 8 | 4.2 |
| One organism | 107 | 56 |
| Two organisms | 6 | 3.2 |
Types and Number of Isolates Detected in Each Group with Childhood Acute Bacterial Conjunctivitis
| Isolated microorganism | Group A | Group B | Group C |
|---|---|---|---|
|
| |||
|
| 19 (55.9) | 10 (15.9) | 7 (31.9) |
|
| 5 (14.7) | 9 (14.3) | 3 (13.6) |
|
| |||
|
| 4 (11.9) | 1 (1.6) | 1 (4.5) |
|
| - | 9 (14.3) | 3 (13.6) |
|
| - | 1 (1.6) | - |
|
| |||
|
| 1 (2.9) | 7 (11.1) | 1 (4.5) |
|
| 2 (5.9) | 17 (26.9) | 6 (27.4) |
|
| 1 (2.9) | - | - |
|
| 1 (2.9) | 1 (1.6) | - |
|
| 1 (2.9) | 3 (4.7) | - |
|
| - | 2 (3.1) | - |
|
| - | 1 (1.6) | - |
|
| - | 1 (1.6) | 1 (4.5) |
|
| - | 1 (1.6) | - |
Group A: included neonates under 28 days of life; Group B: children from 1 month to 2 years; Group C: children from 2 years to 14 years; n: number; %: percentage
Figure 1Seasonal Distribution of the 3 Main Pathogens Isolated From Specimens of Childhood Acute Bacterial Conjunctivitis
Sensitivity of the Isolated Microorganisms in Childhood Acute Bacterial Conjunctivitis. The Numbers in the Parentheses Demonstrate Evaluated Number (n) of Isolates. (R: Resistant, S: Sensitive, I: Intermediate Resistant)
| MICROORGANISM | ||||
|---|---|---|---|---|
| Antibiotics |
|
|
|
|
|
|
|
|
| |
| Ampicillin | (49) 44.9%/ 55.1%/ 0% | (13) 84.6%/ 15.4%/ 0% | (25) 28%/ 72%/ 0% | (5) 0%/ 100%/ 0% |
| Cefuroxime | (60) 11.7%/ 88.3%/ 0% | (15) 13.3%/ 86.7%/ 0% | (31) 12.9%/ 87.1%/ 0% | (8) 0%/ 100%/ 0% |
| Ceftazidime | (24) 20.8%/ 70.8%/ 8.4% | (10)40%/ 40%/ 20% | (8) 12.5%/ 87.5%/ 0% | - |
| Ceftriaxone | (13) 23.1%/ 76.9%/ 0% | (4) 50%/ 50%/ 0% | (7) 14.3%/ 85.7%/ 0% | - |
| Sulfamethoxazole | (54) 20.4%/ 77.8%/ 1.8% | (13) 7.7%/ 92.3%/ 0% | (25) 24%/ 72%/ 4% | (9) 11%/ 89%/ 0% |
| Gentamicin | (14) 0%/ 100%/ 0% | (8) 0%/ 100%/ 0% | - | - |
| Amikacin | (16) 0%/ 93.8%/ 6.2% | (10) 0%/ 90%/ 10% | - | - |
| Netilmicin | (5) 0%/ 100%/ 0% | (5) 0%/ 100%/ 0% | - | - |
| Tobramycin | (7) 14.3%/ 85.7%/ 0% | (3) 33.3%/ 66.7%/ 0% | - | - |
| Clarithromycin | (58) 12.1%/ 87.9%/ 0% | (15) 6.7%/ 93.3%/ 0% | (29) 13.8%/ 86.2%/ 0% | (13) 15.4%/ 84.6%/ 0% |
| Vancomycin | (14) 0%/ 100%/ 0% | (6) 0%/ 100%/ 0% | - | (8) 0%/ 100%/ 0% |
| Ciprofloxacin | (44) 2.3%/ 97.7%/ 0% | (11) 9%/ 91%/ 0% | (20) 0%/ 100%/ 0% | (6) 0%/ 100%/ 0% |